Bharat Parenterals consolidated net profit rises 23.26% in the September 2021 quarter
6 months ago•Business Standard
Bharat Parenterals standalone net profit rises 24.34% in the September 2021 quarter
6 months ago•Business Standard
Bharat Parenterals consolidated net profit rises 16.42% in the June 2021 quarter
9 months ago•Business Standard
Bharat Parenterals consolidated net profit declines 73.49% in the March 2021 quarter
11 months ago•Business Standard
Bharat Parenterals stock freezes at 5% upper circuit after receiving a license to manufacture Favipiravir
1 year ago•India Infoline
COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension
1 year ago•Free Press Journal
Bharat Parenterals gets DCGI nod for favipiravir oral suspension
1 year ago•Economic Times
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value